Grey Approved Stamp

FDA Approves Myasthenia Gravis Drug

October 27, 2017

The FDA approved Alexion Pharmaceuticals’ myasthenia gravis medication Soliris (eculizumab) for adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody-positive.

Myasthenia gravis is a progressive autoimmune neuromuscular disease that most commonly begins for women before the age of 40 and men after the age of 60.

Current therapies are ineffective for 10-15 percent of gMG patients, Alexion said.

View today's stories